Thomas J. Schall, Director of Immuneering IMRX, has filed 4 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $101.1K. The latest trade was on 06/11.

TS

TS

Thomas J. Schall

Director

Company

Immuneering IMRX

First filing

24/03/12

Trades

8 trades

Buys / sales

4 / 0

12-month net buying

$101.1K

Last trade

06/11

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
ImmuneeringIMRX	Open-market buy	01/15	01/20	21,645 sh	$4.67	$101,082.15	+40.9%
ImmuneeringIMRX	Open-market buy	25/06/27	25/06/30	9,500 sh	$3.66	$34,770	+21.9%
ImmuneeringIMRX	Open-market buy	25/06/17	25/06/18	40,485 sh	$2.21	$89,471.85	+1396.0%
ImmuneeringIMRX	Open-market buy	24/03/22	24/03/25	2,900 sh	$2.55	$7,395	No record